AIA Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
AIA Group's ELV Position: Q1 2026 in Review
AIA Group reduced its Elevance Health (ELV) stake by 30% in Q1 2026, selling an estimated $7.02M and leaving 49,186 shares worth $14.4M. The position accounts for 0.21% of the portfolio, ranked #68.
AIA Group first reported a position in ELV in Q1 2021 and has held it in 20 quarters since. The position peaked at $24.7M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- AIA Group held 49,186 shares of Elevance Health worth $14.4M as of Q1 2026.
- AIA Group sold 21,370 Elevance Health shares in Q1 2026, an estimated $7.02M.
- Elevance Health made up 0.21% of AIA Group's portfolio in Q1 2026, its #68 holding.
- AIA Group first reported a position in Elevance Health in Q1 2021 and has held it in 20 quarters since.
- AIA Group's Elevance Health position peaked at $24.7M in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.